Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.58M Buy
+15,768
New +$2.42M 0.18% 190
2025
Q1
Sell
-2,947
Closed -$203K 569
2024
Q4
$203K Buy
+2,947
New +$212K 0.03% 419
2024
Q2
Sell
-9,324
Closed -$253K 570
2024
Q1
$253K Sell
9,324
-2,440
-21% -$68.3K 0.03% 444
2023
Q4
$365K Sell
11,764
-437
-4% -$11.3K 0.06% 327
2023
Q3
$308K Sell
12,201
-30,512
-71% -$698K 0.07% 319
2023
Q2
$901K Buy
42,713
+2,489
+6% +$47.2K 0.34% 66
2023
Q1
$686K Buy
40,224
+17,293
+75% +$336K 0.37% 71
2022
Q4
$458K Sell
22,931
-21,277
-48% -$411K 0.23% 95
2022
Q3
$952K Buy
44,208
+27,214
+160% +$652K 0.33% 95
2022
Q2
$335K Sell
16,994
-4,830
-22% -$101K 0.15% 141
2022
Q1
$513K Sell
21,824
-21,620
-50% -$502K 0.24% 96
2021
Q4
$1.18M Buy
+43,444
New +$1.24M 0.2% 95
2019
Q4
Sell
-296,365
Closed -$5.23M 267
2019
Q3
$5.23M Sell
296,365
-190,610
-39% -$3.68M 0.36% 98
2019
Q2
$12.5M Buy
486,975
+159,391
+49% +$4.44M 0.81% 25
2019
Q1
$9.52M Sell
327,584
-482,300
-60% -$12.5M 0.81% 30
2018
Q4
$10.6M Buy
+809,884
New +$12.9M 1.05% 16

Other funds holding INSM

Atom Investors's INSM Position: Q1 2026 in Review

Atom Investors opened a new position in Insmed (INSM) in Q1 2026: 15,768 shares worth $2.58M. The stake represents 0.18% of the portfolio and ranks #190 among its holdings. This is a return to the name: Atom Investors previously reported a position in INSM as recently as Q4 2024.

Atom Investors first reported a position in INSM in Q4 2018 and has held it in 16 quarters since. The position peaked at $12.5M in Q2 2019. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Atom Investors held 15,768 shares of Insmed worth $2.58M as of Q1 2026.
  • Insmed was a new Atom Investors position in Q1 2026.
  • Insmed made up 0.18% of Atom Investors's portfolio in Q1 2026, its #190 holding.
  • Atom Investors first reported a position in Insmed in Q4 2018 and has held it in 16 quarters since.
  • Atom Investors's Insmed position peaked at $12.5M in Q2 2019.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.